← back to search

Élisabeth Maillart

Sorbonne Université · FR
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, and Systemic Lupus Erythematosus Research.
h-index
36
citations
4,771
works
277
NIH funding
primary concept
email

Recent publications

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis
JAMA 2025cited by 54position: middledoi
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Neurology 2025cited by 10position: middledoi
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis
Neurology 2025cited by 8position: middledoi
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis
Neurology Neuroimmunology & Neuroinflammation 2025cited by 4position: middledoi
Choroid plexus enlargement and Kappa light chains index reflect distinct pathophysiological processes in Multiple Sclerosis
Multiple Sclerosis and Related Disorders 2025cited by 3position: middledoi
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
JAMA Neurology 2024cited by 44position: middledoi
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
JAMA Neurology 2024cited by 32position: middledoi
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis
Brain 2024cited by 22position: middledoi
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis
JAMA Neurology 2024cited by 22position: middledoi
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis
Neurology 2024cited by 5position: middledoi
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
Frontiers in Immunology 2023cited by 129position: middledoi
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks
American Journal of Ophthalmology 2023cited by 62position: middledoi
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
Neurology 2023cited by 23position: middledoi
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
JAMA Neurology 2022cited by 111position: middledoi
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
Journal of Neuroinflammation 2022cited by 63position: middledoi
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Neurology 2022cited by 46position: middledoi
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society
Multiple Sclerosis Journal 2022cited by 42position: middledoi
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society
Multiple Sclerosis Journal 2022cited by 28position: middledoi
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease
Multiple Sclerosis Journal 2022cited by 17position: middledoi
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference
Neurology 2022cited by 17position: middledoi
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
JAMA Network Open 2021cited by 84position: middledoi
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica
Annals of Clinical and Translational Neurology 2021cited by 41position: middledoi
MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis
Multiple Sclerosis and Related Disorders 2021cited by 15position: middledoi
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Annals of Neurology 2020cited by 258position: middledoi
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Multiple Sclerosis and Related Disorders 2020cited by 178position: middledoi
Sex effects across the lifespan in women with multiple sclerosis
Therapeutic Advances in Neurological Disorders 2020cited by 99position: middledoi
Evaluation of efficacy and tolerability of first-line therapies in NMOSD
Neurology 2020cited by 94position: middledoi
MRI characteristics of MOG-Ab associated disease in adults: An update
Revue Neurologique 2020cited by 26position: middledoi
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
European Journal of Neurology 2020cited by 21position: middledoi
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML
European Radiology 2020cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mikaël Cohen · Southwestern Medical Center8 papers (2019–2023)Hélène Zéphir · Université Claude Bernard Lyon 18 papers (2019–2023)Romain Marignier · Hospices Civils de Lyon8 papers (2019–2023)Sandra Vukusic · Université Claude Bernard Lyon 18 papers (2019–2022)Bertrand Bourre · Université Claude Bernard Lyon 18 papers (2019–2023)Nicolas Collongues · Université Claude Bernard Lyon 17 papers (2019–2023)Bertrand Audoin · Université Claude Bernard Lyon 17 papers (2019–2023) · 7 papers (2019–2025)Jonathan Ciron · Université Claude Bernard Lyon 17 papers (2019–2023)Caroline Papeix · Université Claude Bernard Lyon 17 papers (2019–2023)David Laplaud · Université Claude Bernard Lyon 16 papers (2020–2023)de Sèze · Hôpital d'Hautepierre6 papers (2019–2023)Xavier Ayrignac · Université Claude Bernard Lyon 15 papers (2019–2023)Aurélie Ruet · Université Claude Bernard Lyon 14 papers (2020–2023)Pierre Labauge · Université Claude Bernard Lyon 14 papers (2019–2022)Caroline Papeix · Fondation Ophtalmologique Adolphe de Rothschild3 papers (2019–2025)Françoise Durand‐Dubief · Lyon College3 papers (2019–2023)Ayman Tourbah · Université Claude Bernard Lyon 13 papers (2019–2021)Céline Louapre · Centre National de la Recherche Scientifique3 papers (2019–2021)Damien Biotti · Université Claude Bernard Lyon 13 papers (2019–2023)